Immunomodulatory compounds
    3.
    发明授权
    Immunomodulatory compounds 有权
    免疫调节化合物

    公开(公告)号:US07521463B2

    公开(公告)日:2009-04-21

    申请号:US10333605

    申请日:2001-07-31

    摘要: Compounds are described which modulate the tzrosine kinase activity of p56lck and signal transduction pathways in which this enzyme is involved. The invention also relates to compounds which have immunomodulatory activity, e.g., which have immunosuppressant or immunostimulatory activity, and/or which have an antineoplastic effect. The invention further relates to compositions comprising these compounds, and methods of using them. Compounds are described which modulate the tyrosine kinase activity of p56.

    摘要翻译: 描述了调节p56lck的酪氨酸激酶活性和涉及该酶的信号转导途径的化合物。 本发明还涉及具有免疫调节活性的化合物,例如具有免疫抑制剂或免疫刺激活性,和/或具有抗肿瘤作用。 本发明还涉及包含这些化合物的组合物及其使用方法。 描述了调节p56酪氨酸激酶活性的化合物。